SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001689813-19-000071
Filing Date
2019-10-25
Accepted
2019-10-25 20:39:51
Documents
1
Period of Report
2019-10-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_157205036147621.html 4  
1 FORM 4 wf-form4_157205036147621.xml 4 7701
  Complete submission text file 0001689813-19-000071.txt   9075
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Issuer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address (203) 404-0410
Stock Elyse (Reporting) CIK: 0001785732 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38080 | Film No.: 191171014